The Equine Supplement Products Market is expected to reach US$ 1,15,932.42 thousand in 2027 from US$ 89,436.31 thousand in 2021. The market is estimated to grow with a CAGR of 3% from 2021 to 2027.
Equine Infectious Anemia (EIA) is a retroviral disease of the equine that may be characterized by acute and/or chronic recurrent clinical signs, including fever and anemia. Equine infectious anemia virus occurs in horses and ponies and has also been reported in mules, enemas, and cachexia. Animals with equine disease are given supplements that are offered to complete something, make up for a deficiency, or expand or strengthen the whole.
(Get 15% Discount on Buying this Report)
A full report of Global Equine Supplement Products Market is available at: https://www.orionmarketreports.com/equine-supplement-products-market/61435/
Market Segments
By Supplements
- Electrolytes/minerals
- Vitamins
- Proteins/Amino Acids
- Enzymes
By Application
- Performance Enhancement/Recovery
- Join Disorder Prevention
- Others
By Distribution Channel
- Veterinary Hospital Pharmacies and Clinics
- Retail Pharmacies and Drug store
- Online
Key Players
Key players profiled in the market report include Zoetis, Boehringer Ingelheim International GmbH, Bayer AG, Equine Products UK LTD, Purina Animal Nutrition LLC., Vetoquinol S.A., Kentucky Equine Research, Plusvital Limited, Lallemand Inc., and Virbac.
Scope of the Report
The research study analyzes the global Equine Supplement Products industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Equine Supplement Products Market Report
1. What was the Equine Supplement Products Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Equine Supplement Products Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Equine Supplement Products Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Equine Supplement Products market.
- The market share of the global Equine Supplement Products market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Equine Supplement Products market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Equine Supplement Products market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
